Skip to main content
. 2023 Feb 7;4(3):188–195. doi: 10.1093/ehjdh/ztad006

Table 1.

Baseline clinical and echocardiographic characteristics (n = 1035)

Variable Value
Age, years 60 ± 17
Gender, female 187 (18)
BMI, kg/m2 28 ± 5
BSA, m2 2.0 ± 0.2
SBP, mm Hg (n = 1034) 131 ± 20
DBP, mm Hg (n = 1034) 64 ± 13
Diabetes 109 (11)
Hypertension 494 (48)
Chronic lung disease 99 (10)
Hyperlipidaemia 392 (38)
Charlson comorbidity index (n = 1033) 1.6 ± 2.2
NYHA functional class (n = 1016)
ȃI 637 (63)
ȃII 265 (26)
ȃIII 106 (10)
ȃIV 8 (1)
Bicuspid aortic valve morphology (n = 1029) 366 (36)
LV EF, % 58 ± 9
LVEDD, mm (n = 1033) 60 ± 7
Indexed LVEDD, mm/m2 (n = 1033) 30 ± 4
LVESD, mm (n = 1018) 40 ± 7
Indexed LVESD, mm/m2 (n = 1018) 20 ± 4
LVEDV, mL 209 ± 67
Indexed LVEDV, mL/m2 104 ± 30
LVESV, mL 91 ± 41
Indexed LVESV, mL/m2 45 ± 20
Degree of AR
ȃModerate to severe 436 (42)
ȃSevere 599 (58)
Regurgitant volume, mL (n = 885) 71 ± 25
Effective regurgitant orifice area, mm2 (n = 832) 26 ± 14
Vena contracta, mm (n = 709) 6 ± 3
Medial E/e′ ratio (n = 962) 12 ± 24
RVSP, mm Hg (n = 785) 32 ± 10
Mid-ascending aorta, mm (n = 941) 41 ± 7
Mid-ascending aorta ≥ 45 mm 233 (25)
Mid-ascending aorta ≥ 50 mm 95 (10)
Mid-ascending aorta ≥ 55 mm 35 (4)
Sinus of Valsalva, mm (n = 971) 41 ± 6
Sinus of Valsalva ≥ 45 mm 229 (24)
Sinus of Valsalva ≥ 50 mm 53 (5)

Data are expressed as mean ± SD or number (percentage).

Abbreviations: BMI, body mass index; BSA, body surface area; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; AR, aortic regurgitation; TR, tricuspid regurgitation; E/e′, early mitral inflow/tissue Doppler velocity; RVSP, right ventricular systolic pressure.